Cargando…
Protein-Capped Metal Nanoparticles Inhibit Tau Aggregation in Alzheimer’s Disease
[Image: see text] The Alzheimer’s disease (AD) therapeutic research is yielding a large number of potent molecules. The nanoparticle-based therapeutics against the protein aggregation in AD is also taking a lead especially with amyloid-β as a primary target. In this work, we have screened for the fi...
Autores principales: | Sonawane, Shweta Kishor, Ahmad, Absar, Chinnathambi, Subashchandrabose |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2019
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6682074/ https://www.ncbi.nlm.nih.gov/pubmed/31460408 http://dx.doi.org/10.1021/acsomega.9b01411 |
Ejemplares similares
-
Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation
por: Sonawane, Shweta Kishor, et al.
Publicado: (2021) -
Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network
por: Sonawane, Shweta Kishor, et al.
Publicado: (2021) -
EGCG impedes human Tau aggregation and interacts with Tau
por: Sonawane, Shweta Kishor, et al.
Publicado: (2020) -
Photoexcited Toluidine Blue Inhibits Tau Aggregation
in Alzheimer’s Disease
por: Dubey, Tushar, et al.
Publicado: (2019) -
The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau
por: Balmik, Abhishek Ankur, et al.
Publicado: (2021)